VEXAS Syndrome Latest Advances

Find the Latest Research About VEXAS Syndrome

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 592 publications

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

CRE26-064: Evolving Clonal Landscape of VEXAS Syndrome Associated With Myelodysplastic Syndrome: Single Centered, 2 Years Longitudinal Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

VEXAS Syndrome with an Improvement of Chest Shadows Without Immunosuppressive Therapy: A Case Report.

VEXAS Syndrome with an Improvement of Chest Shadows Without Immunosuppressive Therapy: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: March 18, 2026

Correction: VEXAS: A review of current understandings and emerging treatment strategies.

Correction: VEXAS: A review of current understandings and emerging treatment strategies.

Journal: Frontiers in immunology

Published: February 09, 2026

Beyond Sweet Syndrome: Untangling the Threads of Histiocytoid Sweet Syndrome and Cutaneous Myeloid Neoplasia.

Beyond Sweet Syndrome: Untangling the Threads of Histiocytoid Sweet Syndrome and Cutaneous Myeloid Neoplasia.

Journal: Surgical pathology clinics

Published: February 06, 2026

A vexing fever: Unveiling VEXAS syndrome.

A vexing fever: Unveiling VEXAS syndrome.

Journal: The American journal of medicine

Published: February 02, 2026

In response to Bergonzi et al.: Azacitidine-ruxolitinib combination therapy may permit dose reduction in VEXAS syndrome.

In response to Bergonzi et al.: Azacitidine-ruxolitinib combination therapy may permit dose reduction in VEXAS syndrome.

Journal: British journal of haematology

Published: January 29, 2026

Rapid cutaneous remission response to tofacitinib and systemic corticosteroids in VEXAS syndrome with a novel UBA1 mutation.

Rapid cutaneous remission response to tofacitinib and systemic corticosteroids in VEXAS syndrome with a novel UBA1 mutation.

Journal: JAAD case reports

Published: January 19, 2026

Expanding the Clinical Spectrum of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: The First Report of Histologically Confirmed Neutrophilic Colitis With Rare Muscular and Pancreatic Involvement.

Expanding the Clinical Spectrum of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: The First Report of Histologically Confirmed Neutrophilic Colitis With Rare Muscular and Pancreatic Involvement.

Journal: Cureus

Published: January 16, 2026

A Case of VEXAS Syndrome.

A Case of VEXAS Syndrome.

Journal: WMJ : official publication of the State Medical Society of Wisconsin

Published: January 07, 2026

Nailfold capillary abnormalities in VEXAS syndrome.

Nailfold capillary abnormalities in VEXAS syndrome.

Journal: Clinical rheumatology

Published: January 06, 2026

VEXAS Syndrome with Vibrio vulnificus Sepsis During Treatment with Tocilizumab: A Case Report.

VEXAS Syndrome with Vibrio vulnificus Sepsis During Treatment with Tocilizumab: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: January 04, 2026

A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report.

A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report.

Journal: The American journal of case reports

Published: January 03, 2026

Showing 1-12 of 592

Last Updated: 04/28/2026